Featured News

The Celiac Disease Foundation announces its newest appointee, Casey Guber, to its Board of Directors.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.

I am pleased to share a research grant awarded to the Dubcovsky Lab at UC Davis for Development of a Novel Dietary Treatment for Celiac Disease that may significantly reduce the suffering experienced by our patient community.

Thanks to your support, we have been remarkably successful in advancing our shared mission over the past year. What follows are some highlights of some of our most important accomplishments.

My appointment to PCORI’s Advisory Panel on Patient Engagement has just ended. It was a productive and enlightening three-year engagement that has helped inform my ongoing service to the celiac…

We are proud to announce that the Celiac Disease Foundation has received a 100 Overall Score from Charity Navigator.

We are pleased to share the video recording of Dr. Jocelyn Silvester discussing what you need to know about pediatric celiac disease now and in the future.

At UEGW, researchers from Takeda, the University of Sheffield, Columbia University, Coeliac UK, and CDF virtually presented a study entitled, Experiences of a gluten-free diet in patients with celiac disease: a multi-national survey.

CDF Proud Sponsor Nestlé offers more than 25 gluten-free options to ensure consumers have delicious choices regardless of their dietary needs.